The first malaria vaccine candidate to reach phase-3 of clinical testing was found to partially protect children against the disease up to four years after vaccination and may be available by as early as October this year, scientists reported.
from Zee News :Zee News - Health http://bit.ly/1KnxhLp via Health News Daily
No comments:
Post a Comment